V. Fadda

发表

Economic analysis of not running tenders for recombinant Factor VIII procurement: a simplified analysis to estimate an otherwise unknown pharmacoeconomic index

A. Messori, D. Maratea, V. Fadda, 2015, European journal of hospital pharmacy. Science and practice.

High-titre inhibitors in previously untreated patients with severe hemophilia A: an updated estimate of pooled incidence rates in patients treated with plasma-derived concentrates or recombinant Factor VIII

A. Messori, D. Maratea, V. Fadda, 2013 .

Biological drugs for the treatment of rheumatoid arthritis by the subcutaneous route: interpreting efficacy data to assess statistical equivalence

A. Messori, D. Maratea, V. Fadda, 2014, Therapeutic advances in musculoskeletal disease.

Simplified figure to present direct and indirect comparisons: Revisiting the graph 10 years later

A. Messori, V. Fadda, S. Trippoli, 2021, World journal of methodology.

Un’esigenza di chiarezza: differenziare il payback “value-based” da quello non “value-based”

A. Messori, D. Maratea, V. Fadda, 2010 .

Effectiveness of drug-eluting balloons: quantifying the information size from clinical trials.

A. Messori, D. Maratea, V. Fadda, 2013, International journal of cardiology.

New and old anti-thrombotic treatments for patients with atrial fibrillation

A. Messori, D. Maratea, V. Fadda, 2013, International Journal of Clinical Pharmacy.

New endovascular devices for acute ischemic stroke: summarizing evidence by multiple treatment comparison meta-analysis.

A. Messori, D. Maratea, V. Fadda, 2013, Annals of vascular surgery.

Lowering the High Cost of Cancer Drugs--II.

A. Messori, V. Fadda, S. Trippoli, 2016, Mayo Clinic proceedings.

Effect of discounting on estimation of benefits determined by hepatitis C treatment.

A. Messori, D. Maratea, V. Fadda, 2012, World journal of gastroenterology.

Risk of myocardial infarction with oral direct thrombin inhibitors: trial sequential analysis based on two published data sets.

A. Messori, D. Maratea, V. Fadda, 2014, The American journal of cardiology.

Same-day discharge after percutaneous coronary intervention: trial sequential analysis of outcomes.

A. Messori, D. Maratea, V. Fadda, 2014, Journal of the American College of Cardiology.

Biological Drugs for the Treatment of Moderate-to-Severe Psoriasis by Subcutaneous Route: Determining Statistical Equivalence According to Evidence-Based Methods

A. Messori, D. Maratea, V. Fadda, 2014, Clinical Drug Investigation.

Intravenous proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: determining statistical equivalence according to evidence-based methods.

A. Messori, D. Maratea, V. Fadda, 2014, International journal of clinical pharmacology and therapeutics.

Pegylated interferon-α2a versus pegylated interferon-α2b in hepatitis C: reappraisal of effectiveness on the basis of trial sequential analysis.

A. Messori, D. Maratea, V. Fadda, 2014, European journal of gastroenterology & hepatology.

Omega-3 polyunsaturated fatty acids for patients at risk of sudden cardiac death and ventricular arrhythmias: trial sequential analysis.

A. Messori, D. Maratea, V. Fadda, 2013, Heart & lung : the journal of critical care.

Erythropoiesis‐stimulating agents in heart failure: no proof of effectiveness or proof of no effectiveness?

A. Messori, D. Maratea, V. Fadda, 2013, European journal of heart failure.

Off-pump versus on-pump coronary artery bypass grafting: quantifying information size by trial sequential analysis.

A. Messori, D. Maratea, V. Fadda, 2013, European journal of internal medicine.

Intra-aortic balloon pump in high-risk percutaneous coronary interventions without cardiogenic shock: trial sequential analysis of outcomes.

A. Messori, D. Maratea, V. Fadda, 2013, International journal of cardiology.

Sequential analysis shows that β blockade in non-cardiac surgery is ineffective and may even be harmful

A. Messori, D. Maratea, V. Fadda, 2013, BMJ.

Erythropoietin in Patients With Acute Myocardial Infarction: No Proof of Effectiveness or Proof of No Effectiveness?

A. Messori, D. Maratea, V. Fadda, 2013, Clinical cardiology.

Parenteral vs oral iron in patients with inflammatory bowel disease: quantifying information size by trial sequential analysis.

A. Messori, D. Maratea, V. Fadda, 2013, Journal of Crohn's & colitis.

Maintenance Chemotherapy in Ovarian Cancer: A Trial-Sequential Analysis

A. Messori, D. Maratea, V. Fadda, 2013 .

ω-3 fatty acid supplements for secondary prevention of cardiovascular disease: from "no proof of effectiveness" to "proof of no effectiveness".

A. Messori, D. Maratea, V. Fadda, 2013, JAMA internal medicine.

Application of the gompertz method for evaluating survival gains in patients receiving cardiac resynchronization therapy.

A. Messori, D. Maratea, V. Fadda, 2014, Journal of the American College of Cardiology.

Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine

G. Zaccara, F. Giovannelli, A. Verrotti, 2013, Seizure.

Bayesian network meta-analysis to evaluate interferon-free treatments in naive patients with genotype 1 hepatitis C virus infection.

A. Messori, D. Maratea, V. Fadda, 2015, European journal of gastroenterology & hepatology.

Temporal Trend of Overall Survival in Patients with Advanced Non-small Cell Lung Cancer Given First-Line Cytotoxic Treatments

A. Messori, D. Maratea, V. Fadda, 2012, Lung.

Testing the therapeutic equivalence of novel oral anticoagulants for thromboprophylaxis in orthopedic surgery and for prevention of stroke in atrial fibrillation.

A. Messori, D. Maratea, V. Fadda, 2015, International journal of clinical pharmacology and therapeutics.

Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods

A. Messori, D. Maratea, V. Fadda, 2014, Journal of Endocrinological Investigation.

Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban

A. Messori, D. Maratea, V. Fadda, 2014, European Journal of Clinical Pharmacology.

Intramyocardial bone marrow-derived cells for ischemic heart disease: is the benefit clinically relevant?

A. Messori, D. Maratea, V. Fadda, 2014, Atherosclerosis.

1 2 Testing the Therapeutic Equivalence of Alogliptin , 3 Linagliptin , Saxagliptin , Sitagliptin or Vildagliptin 4 as Monotherapy or in Combination with Metformin 5 in Patients with Type 2 Diabetes

A. Messori, D. Maratea, V. Fadda, 2014 .

Outcomes with short-term versus long-term antiplatelet dual therapy after drug-eluting stenting: quantifying the equivalence margins.

A. Messori, D. Maratea, V. Fadda, 2014, International journal of cardiology.

Are Newer-Generation Drug-Eluting Stents More Effective in Women than Early-Generation Ones?

A. Messori, D. Maratea, V. Fadda, 2014 .

Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes

A. Messori, D. Maratea, V. Fadda, 2014, Diabetes Therapy.

Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference

A. Messori, D. Maratea, V. Fadda, 2015, Journal of Endocrinological Investigation.

Comparing benefits expected in the design of randomized trials with the results of mature meta-analysis: an analysis on aspiration thrombectomy in acute myocardial infarction.

A. Messori, D. Maratea, V. Fadda, 2014, International journal of cardiology.

Letter: biological drugs for inducing remission in ulcerative colitis

A. Messori, D. Maratea, V. Fadda, 2014, Alimentary pharmacology & therapeutics.

Dexmedetomidine vs propofol in intensive care unit patients

A. Messori, D. Maratea, V. Fadda, 2014 .

Letter: estimating the cost‐neutral price of sofosbuvir‐based triple therapy for the treatment of naïve patients with genotype 1 HCV infection in Italy

A. Messori, D. Maratea, V. Fadda, 2014, Alimentary pharmacology & therapeutics.

Treatments for relapsing–remitting multiple sclerosis: summarising current information by network meta-analysis

A. Messori, D. Maratea, V. Fadda, 2011, European Journal of Clinical Pharmacology.

Anti-platelet treatments in acute coronary syndrome: simplified network meta-analysis.

A. Messori, D. Maratea, V. Fadda, 2011, International journal of cardiology.

Prevention of Venous Thromboembolism in Major Orthopedic Surgery: Bayesian Network Meta-Analysis of 21 Randomized Trials Evaluating Unfractionated Heparins, Low-Molecular Weight Heparins, and New Oral Anticoagulants

A. Messori, D. Maratea, V. Fadda, 2015 .

Subcutaneous Biological Treatments for Moderate to Severe Psoriasis: Interpreting Safety Data by Network Meta-Analysis

A. Messori, D. Maratea, V. Fadda, 2015, Drugs - Real World Outcomes.

Intracoronary infusion of bone-marrow derived mononuclear cells in acute myocardial infarction: are outcomes influenced by the number of infused cells?

A. Messori, D. Maratea, V. Fadda, 2013, Heart, lung & circulation.

Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma

A. Messori, D. Maratea, V. Fadda, 2015, Leukemia & lymphoma.

Viscosupplementation in patients with knee osteoarthritis: temporal trend of benefits assessed by meta-regression

A. Messori, D. Maratea, V. Fadda, 2014, European Journal of Orthopaedic Surgery & Traumatology.

Dabigatran in atrial fibrillation: incremental benefit over a time horizon of 5 or 10 years

A. Messori, D. Maratea, V. Fadda, 2013, Journal of cardiovascular medicine.

First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis

A. Messori, D. Maratea, V. Fadda, 2015, Annals of Hematology.

Left atrial appendage occlusion devices versus pharmacological agents for stroke prevention in atrial fibrillation: testing the noninferiority margins.

A. Messori, D. Maratea, V. Fadda, 2014, JACC. Cardiovascular interventions.

Study of Bevacizumab vs anibizumab for Age-Related Macular egeneration : Inappropriate onclusions

A. Messori, V. Fadda, S. Trippoli, 2022 .

Interpreting randomised trials evaluating newer agents or interferon in multiple sclerosis

A. Messori, D. Maratea, V. Fadda, 2012, European Journal of Clinical Pharmacology.

Treatments for macular degeneration: summarising evidence using network meta-analysis

A. Messori, D. Maratea, V. Fadda, 2011, British Journal of Ophthalmology.

Letter: first‐line monotherapies for chronic hepatitis B – indirect comparison between entecavir and tenofovir

A. Messori, D. Maratea, V. Fadda, 2013, Alimentary pharmacology & therapeutics.

Nephrotoxicity of different formulations of amphotericin B: summarizing evidence by network meta-analysis.

A. Messori, D. Maratea, V. Fadda, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design

G. Taylor, V. Cowton, A. M. Ortega-Prieto, 2021, NPJ vaccines.

Cost-Effectiveness Evaluation of Oncological Drugs Newly Marketed in Italy

V. Fadda, C. Lucioni, S. Mazzi, 2014, Global and Regional Health Technology Assessment.

New Oncological Drugs: Analysis of Survival Gain

V. Fadda, C. Lucioni, S. Mazzi, 2014, Global and Regional Health Technology Assessment.

Acute lymphoblastic leukemia in first complete remission: temporal trend of outcomes in studies comparing allogeneic transplant with autologous transplant or chemotherapy

A. Messori, D. Maratea, V. Fadda, 2013, Annals of Hematology.

A Uniform Procedure for Reimbursing the Off-Label Use of Antineoplastic Drugs According to the Value-for-Money Approach

A. Messori, V. Fadda, S. Trippoli, 2011, Journal of chemotherapy.

Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome

D. Maratea, V. Fadda, 2016, ClinicoEconomics and outcomes research : CEOR.

Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012.

A. Messori, D. Maratea, V. Fadda, 2014, World journal of clinical oncology.

Mechanical Endovascular Therapy in Ischaemic Stroke: Temporal Trend of Outcomes

A. Messori, D. Maratea, V. Fadda, 2013, International journal of stroke : official journal of the International Stroke Society.

Biologic agents in rheumatoid arthritis: temporal trend of incremental benefits

A. Messori, D. Maratea, V. Fadda, 2012, Therapeutic advances in musculoskeletal disease.

Meta-analysis of observational studies to evaluate immediate outcomes after endarterectomy or stenting for carotid artery stenosis.

A. Messori, D. Maratea, V. Fadda, 2012, Annals of vascular surgery.

Antipsychotic drugs for relapse prevention in schizophrenia

A. Messori, D. Maratea, V. Fadda, 2012, The Lancet.

Results can be summarised in a simple figure

Andrea Messori, Valeria Fadda, Dario Maratea, 2011, BMJ : British Medical Journal.

Stent-Retriever Thrombectomy for Stroke.

A. Messori, V. Fadda, S. Trippoli, 2015, The New England journal of medicine.

Producing evidence in support of disinvestment: The experience of the Tuscany region in Italy.

A. Messori, D. Maratea, V. Fadda, 2016, European journal of internal medicine.

Effectiveness and Cost Effectiveness of Bevacizumab in Metastatic Colorectal Cancer.

L. Pani, A. Messori, V. Fadda, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temporal trend of short-term mortality in severely ill patients receiving parenteral glutamine supplementation.

A. Messori, D. Maratea, V. Fadda, 2013, Clinical nutrition.

Intramuscular IFNß‐1a in multiple sclerosis: ‘no proof of effectiveness’ or ‘proof of no effectiveness’?

A. Messori, D. Maratea, V. Fadda, 2013, European Journal of Neurology.

Rates of Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A Treated with Plasma-Derived or Recombinant Factor VIII: No Proof of Difference or Proof of No Difference?

A. Messori, D. Maratea, V. Fadda, 2014, Seminars in Thrombosis & Hemostasis.

Prevention of venous thromboembolism after major orthopedic surgery: indirect comparison of three new oral anticoagulants

A. Messori, D. Maratea, V. Fadda, 2011, Journal of thrombosis and haemostasis : JTH.

Treatments for relapsing–remitting multiple sclerosis: summarising current information by network meta-analysis

A. Messori, D. Maratea, V. Fadda, 2012, European Journal of Clinical Pharmacology.

Indirect meta-analytical comparison of azathioprine and of beta interferon effectiveness in all forms of multiple sclerosis pooled together

A. Messori, D. Maratea, V. Fadda, 2014, Journal of the Neurological Sciences.

Differentiating between “no proof of difference” and “proof of no difference” for new oral anticoagulants

A. Messori, D. Maratea, V. Fadda, 2014, BMJ : British Medical Journal.

All-cause mortality in patients with unprotected left main coronary disease: comparison between stenting and coronary artery bypass grafting.

A. Messori, D. Maratea, V. Fadda, 2013, The American journal of cardiology.

Outcomes in patients with unprotected left main coronary disease: comparison between drug-eluting stents and coronary artery by-pass grafting.

A. Messori, D. Maratea, V. Fadda, 2013, The American journal of cardiology.

New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?

A. Messori, D. Maratea, V. Fadda, 2014, International cardiovascular research journal.

Supplementation of n-3 polyunsaturated fatty acids to prevent postoperative atrial fibrillation in patients subjected to heart surgery.

A. Messori, D. Maratea, V. Fadda, 2013, Journal of Thoracic and Cardiovascular Surgery.

Managing Tenders in the Procurement of Advanced Medical Devices: An Original Model Based on the Net Monetary Benefit Combined With Three Clinical Endpoints

A. Messori, V. Fadda, S. Trippoli, 2023, Cureus.

Nationwide prediction of future expenditure for protease inhibitors in chronic hepatitis C.

A. Messori, D. Maratea, V. Fadda, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Glutamine in critically ill patients: trial-sequential analysis.

A. Messori, D. Maratea, V. Fadda, 2014, Clinical nutrition.

Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012.

A. Messori, D. Maratea, V. Fadda, 2014, World journal of clinical oncology.

Using risk difference as opposed to odds-ratio in meta-analysis.

A. Messori, D. Maratea, V. Fadda, 2013, International Journal of Cardiology.